121 related articles for article (PubMed ID: 28111136)
1. Potential of glycative stress targeting for cancer prevention.
Piperi C; Adamopoulos C; Papavassiliou AG
Cancer Lett; 2017 Apr; 390():153-159. PubMed ID: 28111136
[TBL] [Abstract][Full Text] [Related]
2. RAGE and glyoxalase in kidney disease.
Inagi R
Glycoconj J; 2016 Aug; 33(4):619-26. PubMed ID: 27270765
[TBL] [Abstract][Full Text] [Related]
3. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.
Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC
Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083
[TBL] [Abstract][Full Text] [Related]
4. Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.
Hirakawa Y; Inagi R
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106734
[TBL] [Abstract][Full Text] [Related]
5. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review.
Fleming TH; Humpert PM; Nawroth PP; Bierhaus A
Gerontology; 2011; 57(5):435-43. PubMed ID: 20962515
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.
Tesarova P; Zima T; Kubena AA; Kalousova M
Tumour Biol; 2017 Jul; 39(7):1010428317702902. PubMed ID: 28695773
[TBL] [Abstract][Full Text] [Related]
7. Do all roads lead to the Rome? The glycation perspective!
Ahmad S; Akhter F; Shahab U; Rafi Z; Khan MS; Nabi R; Khan MS; Ahmad K; Ashraf JM; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():9-19. PubMed ID: 29113952
[TBL] [Abstract][Full Text] [Related]
8. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
Rabbani N; Xue M; Thornalley PJ
Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
[TBL] [Abstract][Full Text] [Related]
9. Role of age and uncoupling protein-2 in oxidative stress, RAGE/AGE interaction and inflammatory liver injury.
Kuhla A; Trieglaff C; Vollmar B
Exp Gerontol; 2011 Nov; 46(11):868-76. PubMed ID: 21820503
[TBL] [Abstract][Full Text] [Related]
10. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
Sakellariou S; Fragkou P; Levidou G; Gargalionis AN; Piperi C; Dalagiorgou G; Adamopoulos C; Saetta A; Agrogiannis G; Theohari I; Sougioultzis S; Tsioli P; Karavokyros I; Tsavaris N; Kostakis ID; Zizi-Serbetzoglou A; Vandoros GP; Patsouris E; Korkolopoulou P
BMC Cancer; 2016 Mar; 16():174. PubMed ID: 26931562
[TBL] [Abstract][Full Text] [Related]
12. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy.
Aragonès G; Rowan S; Francisco SG; Whitcomb EA; Yang W; Perini-Villanueva G; Schalkwijk CG; Taylor A; Bejarano E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440621
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effect of Multimodal Nanoassemblies against Glycative and Oxidative Stress in Cancer and Glycation Animal Models.
Khan H; Waseem M; Faisal M; Alatar AA; Qahtan AA; Ahmad S
Biomed Res Int; 2021; 2021():8892156. PubMed ID: 33928164
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and adipocyte biology: focus on the role of AGEs.
Boyer F; Vidot JB; Dubourg AG; Rondeau P; Essop MF; Bourdon E
Oxid Med Cell Longev; 2015; 2015():534873. PubMed ID: 25878764
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic targeting of advanced glycation end-products in age-related diseases.
Rowan S; Bejarano E; Taylor A
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3631-3643. PubMed ID: 30279139
[TBL] [Abstract][Full Text] [Related]
16. Prevention of dicarbonyl-mediated advanced glycation by glyoxalases: implication in skin aging.
Radjei S; Friguet B; Nizard C; Petropoulos I
Biochem Soc Trans; 2014 Apr; 42(2):518-22. PubMed ID: 24646271
[TBL] [Abstract][Full Text] [Related]
17. DNA aptamer raised against advanced glycation end products (AGEs) improves glycemic control and decreases adipocyte size in fructose-fed rats by suppressing AGE-RAGE axis.
Ojima A; Matsui T; Nakamura N; Higashimoto Y; Ueda S; Fukami K; Okuda S; Yamagishi S
Horm Metab Res; 2015 Apr; 47(4):253-8. PubMed ID: 25105541
[TBL] [Abstract][Full Text] [Related]
18. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose.
Kim KM; Kim YS; Jung DH; Lee J; Kim JS
Exp Cell Res; 2012 Jan; 318(2):152-9. PubMed ID: 22036650
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress.
Hirakawa Y; Jao TM; Inagi R
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():70-77. PubMed ID: 28467603
[TBL] [Abstract][Full Text] [Related]
20. Glabridin Alleviates the Toxic Effects of Methylglyoxal on Osteoblastic MC3T3-E1 Cells by Increasing Expression of the Glyoxalase System and Nrf2/HO-1 Signaling and Protecting Mitochondrial Function.
Choi EM; Suh KS; Kim YJ; Hong SM; Park SY; Chon S
J Agric Food Chem; 2016 Jan; 64(1):226-35. PubMed ID: 26670935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
